SLN

#2809
Silence Therapeutics Plc - American Depository Share
6.9 0 USD
+0.44%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
6.90
6.90
년간 변동
4.19
8.40
일일 변동
+0.44%
월간 변동
-4.43%
6달 변화
+4.07%
년간 변동율
+14.24%
이전 종가
6.8 7
Open
6.9 0
저가
6.9 0
High
6.9 0
양
29
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 325.92 M
  • Employee 88
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-9.65
주가매출액비율
1 541.15

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

뉴스